King's Innovation Catalyst
Your gateway to innovation at King’s.
Our portfolio includes breakthrough ventures in healthcare (from diagnostic to therapeutics and medical devices), physical sciences (IT, telecommunications and robotics) social sciences, humanities and the arts.
King's Innovation Catalyst's award-winning IP & Licensing team is the first point-of-contact for potential investors across industry and venture capital funds.
Our IP & Licensing Team is responsible for all commercial transactions, including spinouts negotiations. We lead on :
For founder-led spinouts, discussions are driven by the founding team with potential investors, with advice from our innovation experts.
We have a model of active shareholding which promotes our ambitious ecosystem for innovation across the university.
Our IP Code of Practice promises:
To discuss investment options for specific spinouts, please connect with our IP & Licensing Team.
You can find the University’s terms for governing the ownership, protection and commercial exploitation of intellectual property created by our staff, students and any non-employed visitors in the Intellectual Property, Commercial Exploitation & Financial Benefits Code of Practice.
King's is supportive of the recommendations made in the 2023 Independent Review of University Spin-out Companies. We have substantively adopted these, working towards full adoption. Further details can be found in our updated Intellectual Property, Commercial Exploitation & Financial Benefits Code of Practice.
To discuss terms and the licensing process in more detail, please connect with our IP & Licensing Team.
For any other queries related to King's Innovation Catalyst services, please email: innovation@kcl.ac.uk.
Your gateway to innovation at King’s.
Invest in our spinout and licensing opportunities.
Exclusive access to King's cutting-edge ventures and spinouts.